Search Results - "Terleira‐Fernández, Ana‐Isabel"
-
1
Causes of Death in Anticoagulated Patients With Atrial Fibrillation
Published in Journal of the American College of Cardiology (13-12-2016)“…Abstract Background Oral anticoagulation reduces the risk of mortality in atrial fibrillation (AF), but examination of the causes of death is essential to…”
Get full text
Journal Article -
2
Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives
Published in European journal of haematology (01-11-2015)“…In recent years, several direct‐acting oral anticoagulants (DOAC) have become available for use in Europe and other regions in indications related to…”
Get full text
Journal Article -
3
Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta‐analysis by geographic region with a focus on European patients
Published in British journal of clinical pharmacology (01-09-2016)“…Aims To analyse clinical outcomes with direct oral anticoagulants in patients with atrial fibrillation according to geographic region. Methods We…”
Get full text
Journal Article -
4
Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review
Published in Vascular health and risk management (01-01-2014)“…Pulmonary embolism (PE) is a relatively common cardiovascular emergency. PE and deep vein thrombosis (DVT) are considered expressions of the same disease,…”
Get full text
Journal Article -
5
Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis
Published in Thrombosis research (01-10-2014)“…Abstract Introduction Acute venous thromboembolism (VTE) is a common disease associated to significant morbidity and mortality. Materials and methods We…”
Get full text
Journal Article -
6
Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
Published in PharmacoEconomics (01-09-2014)“…Background Patients undergoing total hip replacement (THR) or total knee replacement (TKR) surgery are at high risk of developing venous thromboembolism (VTE)…”
Get full text
Journal Article -
7
Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
Published in Journal of the American College of Cardiology (22-06-2021)“…Direct oral anticoagulants (DOACs) have shown a positive benefit-risk balance in both clinical trials and real-world data, but approximately 2% to 3.5% of…”
Get full text
Journal Article -
8
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
Published in BMJ (Online) (14-06-2012)“…Objective To analyse clinical outcomes with new oral anticoagulants for prophylaxis against venous thromboembolism after total hip or knee replacement.Design…”
Get full text
Journal Article -
9
Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis
Published in Seminars in thrombosis and hemostasis (01-06-2018)“…Death is more frequent than nonfatal recurrent venous thromboembolism (VTE) and major bleeding after acute VTE. The analysis of the causes of death is…”
Get more information
Journal Article -
10
Discovery of anticoagulant drugs: a historical perspective
Published in Current drug discovery technologies (01-06-2012)“…The history of the traditional anticoagulants is marked by both perseverance and serendipity. The anticoagulant effect of heparin was discovered by McLean in…”
Get more information
Journal Article -
11
Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients
Published in Vascular health and risk management (01-01-2013)“…Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, represents a major cause of morbidity and mortality in patients with…”
Get full text
Journal Article -
12
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation : A Systematic Review and Meta-Analysis of Subgroups
Published in Thrombosis (01-01-2013)“…Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in…”
Get full text
Journal Article -
13
Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review
Published in Journal of cardiovascular pharmacology and therapeutics (01-09-2015)“…In patients with venous thromboembolism (VTE), the study of the case fatality rate (CFR) of VTE recurrences and bleeding complications may be of help to…”
Get more information
Journal Article